BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21693726)

  • 41. Anti-parietal cell antibody and serum pepsinogen assessment in screening for gastric carcinoma.
    Sugiu K; Kamada T; Ito M; Kaya S; Tanaka A; Kusunoki H; Hata J; Haruma K
    Dig Liver Dis; 2006 May; 38(5):303-7. PubMed ID: 16549394
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combining the serum pepsinogen level and Helicobacter pylori antibody test for predicting the histology of gastric neoplasm.
    Choi HS; Lee SY; Kim JH; Sung IK; Park HS; Shim CS; Jin CJ
    J Dig Dis; 2014 Jun; 15(6):293-8. PubMed ID: 24602176
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk of gastric cancer in Helicobacter pylori infection in a 15-year follow-up.
    Vohlonen I; Pukkala E; Malila N; Härkönen M; Hakama M; Koistinen V; Sipponen P
    Scand J Gastroenterol; 2016 Oct; 51(10):1159-64. PubMed ID: 27338132
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status.
    Hansen S; Vollset SE; Derakhshan MH; Fyfe V; Melby KK; Aase S; Jellum E; McColl KE
    Gut; 2007 Jul; 56(7):918-25. PubMed ID: 17317788
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison on Clinicopathological Features and Prognosis Between Esophagogastric Junctional Adenocarcinoma (Siewert II/III Types) and Distal Gastric Adenocarcinoma: Retrospective Cohort Study, a Single Institution, High Volume Experience in China.
    Liu K; Zhang W; Chen X; Chen X; Yang K; Zhang B; Chen Z; Zhou Z; Hu J
    Medicine (Baltimore); 2015 Aug; 94(34):e1386. PubMed ID: 26313779
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Helicobacter pylori infection in gastric carcinoma.
    Kato T; Saito Y; Niwa M; Inoue H; Motoyama N; Ogoshi K; Nashimoto A; Sasaki J; Sato T; Asaka M
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S93-6. PubMed ID: 7735944
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysis.
    Yeh JM; Hur C; Ward Z; Schrag D; Goldie SJ
    Gut; 2016 Apr; 65(4):563-74. PubMed ID: 25779597
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Different etiological role of Helicobacter pylori (Hp) infection in carcinogenesis between differentiated and undifferentiated gastric cancers: a nested case-control study using IgG titer against Hp surface antigen.
    Tatemichi M; Sasazuki S; Inoue M; Tsugane S;
    Acta Oncol; 2008; 47(3):360-5. PubMed ID: 18347999
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Programmed death-1 polymorphisms is associated with risk of esophagogastric junction adenocarcinoma in the Chinese Han population: A case-control study involving 2,740 subjects.
    Tang W; Chen S; Chen Y; Lin J; Lin J; Wang Y; Liu C; Kang M
    Oncotarget; 2017 Jun; 8(24):39198-39208. PubMed ID: 28487496
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Circulating ghrelin levels in patients with various upper gastrointestinal diseases.
    Isomoto H; Ueno H; Nishi Y; Yasutake T; Tanaka K; Kawano N; Ohnita K; Mizuta Y; Inoue K; Nakazato M; Kohno S
    Dig Dis Sci; 2005 May; 50(5):833-8. PubMed ID: 15906753
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatocyte Growth Factor in Blood and Gastric Cancer Risk: A Nested Case-Control Study.
    Jang J; Ma SH; Ko KP; Choi BY; Yoo KY; Park SK
    Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):470-476. PubMed ID: 31740519
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Serological Biopsy Using Five Stomach-Specific Circulating Biomarkers for Gastric Cancer Risk Assessment: A Multi-Phase Study.
    Tu H; Sun L; Dong X; Gong Y; Xu Q; Jing J; Bostick RM; Wu X; Yuan Y
    Am J Gastroenterol; 2017 May; 112(5):704-715. PubMed ID: 28323271
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biomarkers for Helicobacter pylori infection and gastroduodenal diseases.
    Shiota S; Yamaoka Y
    Biomark Med; 2014; 8(9):1127-37. PubMed ID: 25402582
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gastric adenocarcinoma in Zambia: a case-control study of HIV, lifestyle risk factors, and biomarkers of pathogenesis.
    Kayamba V; Asombang AW; Mudenda V; Lisulo MM; Sinkala E; Mwanamakondo S; Mweemba I; Kelly P
    S Afr Med J; 2013 Feb; 103(4):255-9. PubMed ID: 23547703
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association between Helicobacter pylori and gastric carcinoma in the city of Malmö, Sweden. A prospective study.
    Simán JH; Forsgren A; Berglund G; Florén CH
    Scand J Gastroenterol; 1997 Dec; 32(12):1215-21. PubMed ID: 9438319
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: analysis of 5732 Japanese subjects.
    Yamaji Y; Mitsushima T; Ikuma H; Okamoto M; Yoshida H; Kawabe T; Shiratori Y; Saito K; Yokouchi K; Omata M
    Gut; 2001 Sep; 49(3):335-40. PubMed ID: 11511553
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum insulin, glucose, indices of insulin resistance, and risk of prostate cancer.
    Albanes D; Weinstein SJ; Wright ME; Männistö S; Limburg PJ; Snyder K; Virtamo J
    J Natl Cancer Inst; 2009 Sep; 101(18):1272-9. PubMed ID: 19700655
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The U-shaped association between body mass index and gastric cancer risk in the Helicobacter pylori Biomarker Cohort Consortium: A nested case-control study from eight East Asian cohort studies.
    Jang J; Wang T; Cai H; Ye F; Murphy G; Shimazu T; Taylor PR; Qiao YL; Yoo KY; Jee SH; Kim J; Chen SC; Abnet CC; Tsugane S; Zheng W; Shu XO; Pawlita M; Park SK; Epplein M
    Int J Cancer; 2020 Aug; 147(3):777-784. PubMed ID: 31745972
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tests for serum levels of trefoil factor family proteins can improve gastric cancer screening.
    Aikou S; Ohmoto Y; Gunji T; Matsuhashi N; Ohtsu H; Miura H; Kubota K; Yamagata Y; Seto Y; Nakajima A; Goldenring JR; Kaminishi M; Nomura S
    Gastroenterology; 2011 Sep; 141(3):837-845.e1-7. PubMed ID: 21699780
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relationship between Helicobacter pylori infection and gastric atrophy and the stages of the oesophageal inflammation, metaplasia, adenocarcinoma sequence: results from the FINBAR case-control study.
    Anderson LA; Murphy SJ; Johnston BT; Watson RG; Ferguson HR; Bamford KB; Ghazy A; McCarron P; McGuigan J; Reynolds JV; Comber H; Murray LJ
    Gut; 2008 Jun; 57(6):734-9. PubMed ID: 18025067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.